Kinsale Capital Q2 Print Arrives With Bears Still Retreating

KNSL reports Q2 results today with positioning that looks more relaxed than the stock's 11% short interest might suggest — a story the data has been telling consistently for several weeks.

Short sellers have continued to pare back. At 10.9% of the free float, the position remains elevated in absolute terms, but the month-on-month reduction of 7.4% confirms that bears have not been adding into the rally — they have been stepping away from it. The borrow market tells the same story: availability has actually loosened further since the prior preview, climbing to 311% from roughly 291% a week ago, comfortably above the 52-week floor of 180%. Cost to borrow remains subdued at 0.51%, barely changed over the past week. No squeeze mechanics, no crowding signal. Options confirm the relaxed tone: the put/call ratio of 0.36 is only marginally above its 20-day average of 0.34, with a z-score of 0.41 — well short of any meaningful hedging signal. The stock itself added 2% on Wednesday to close at $332.28, though it remains about 1% softer on the week.

The bull and bear debate has sharpened around one question: whether the 12% monthly rally has outpaced the fundamentals. Bulls point to Kinsale's underwriting discipline, an expense ratio that continues to trend favorably, and investment income growth — a combination that has kept returns above 20% even as the property insurance market has grown more competitive. JP Morgan lifted its target to $390 on July 20 while holding a Neutral rating, and Wells Fargo nudged its Equal-Weight target to $366 in early July — both acknowledging positive momentum without committing to outright bullishness. Bears are more focused on the casualty division, where pricing pressure from E&S competitors has not eased, and on reserve adequacy, which remains a perennial concern in the specialty lines space. Morgan Stanley sits at Equal-Weight with a $330 target — essentially where the stock traded just a week ago — and Jefferies holds an Underperform at $312. The mean analyst target of $347 leaves only modest upside from current levels, underscoring that consensus is cautious rather than constructive.

One ownership detail is worth noting. CEO Michael Kehoe sold approximately $6.8 million in stock on May 5, a cluster of transactions executed across a single day. He still holds roughly 3.9% of the company — a meaningful personal stake — but the size of the sale, occurring when the stock was trading near $302, is a data point the market has already absorbed with the shares since recovering to $332.

The Q2 print is therefore less a test of whether Kinsale can grow and more a test of whether its combined ratio and casualty loss trends can justify a stock that has already moved sharply higher, even as the Street's consensus barely clears the current price.